OMH SCIENCE Group Co., Ltd
SZSE:300486.SZ
7.03 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 871.976 | 1,143.28 | 1,299.73 | 1,034.516 | 736.322 | 698.105 | 507.674 | 198.94 | 365.652 | 396.115 | 386.52 | 371.822 | 335.65 |
| Cost of Revenue
| 764.474 | 867.477 | 981.176 | 731.67 | 503.357 | 514.111 | 379.848 | 168.695 | 262.315 | 274.801 | 269.837 | 256.957 | 231.791 |
| Gross Profit
| 107.502 | 275.803 | 318.555 | 302.846 | 232.965 | 183.994 | 127.825 | 30.245 | 103.337 | 121.313 | 116.684 | 114.865 | 103.859 |
| Gross Profit Ratio
| 0.123 | 0.241 | 0.245 | 0.293 | 0.316 | 0.264 | 0.252 | 0.152 | 0.283 | 0.306 | 0.302 | 0.309 | 0.309 |
| Reseach & Development Expenses
| 40.465 | 44.23 | 54.173 | 41.664 | 34.992 | 30.339 | 22.285 | 22.682 | 20.835 | 15.15 | 14.384 | 14.506 | 0 |
| General & Administrative Expenses
| 22.054 | 19.883 | 30.994 | 20.475 | 26.626 | 21.042 | 10.887 | 13.506 | 9.318 | 6.586 | 6.751 | 8.65 | 29.633 |
| Selling & Marketing Expenses
| 42.376 | 35.272 | 46.403 | 29.881 | 21.111 | 13.726 | 20.525 | 21.874 | 15.369 | 10.975 | 10.501 | 10.537 | 6.108 |
| SG&A
| 64.429 | 55.155 | 77.397 | 50.356 | 47.737 | 34.768 | 31.411 | 35.38 | 24.687 | 17.561 | 17.252 | 19.187 | 35.74 |
| Other Expenses
| 4.709 | -2.659 | -0.1 | 0.388 | 2.453 | 0.501 | 1.394 | 14.201 | 15.455 | 1.68 | 0.935 | 3.056 | 1.16 |
| Operating Expenses
| 170.811 | 163.449 | 168.514 | 130.892 | 113.415 | 101.929 | 75.764 | 86.698 | 68.97 | 54.494 | 53.167 | 49.799 | 41.541 |
| Operating Income
| -286.897 | 51.863 | 83.738 | 123.438 | 101.505 | 71.11 | 41.867 | -72.548 | 26.812 | 61.115 | 59.796 | 56.267 | 53.011 |
| Operating Income Ratio
| -0.329 | 0.045 | 0.064 | 0.119 | 0.138 | 0.102 | 0.082 | -0.365 | 0.073 | 0.154 | 0.155 | 0.151 | 0.158 |
| Total Other Income Expenses Net
| 4.709 | -2.659 | -0.1 | 0.388 | 2.453 | 0.501 | -0.08 | 14.198 | 14.038 | 1.34 | 0.909 | 1.401 | 1.089 |
| Income Before Tax
| -282.188 | 49.204 | 83.638 | 123.826 | 103.959 | 71.611 | 41.787 | -58.351 | 40.85 | 62.455 | 60.706 | 57.668 | 54.1 |
| Income Before Tax Ratio
| -0.324 | 0.043 | 0.064 | 0.12 | 0.141 | 0.103 | 0.082 | -0.293 | 0.112 | 0.158 | 0.157 | 0.155 | 0.161 |
| Income Tax Expense
| -33.645 | 3.608 | 10.986 | 14.17 | 13.176 | 8.338 | 5.638 | -8.683 | 4.521 | 8.35 | 7.544 | 7.755 | 7.545 |
| Net Income
| -248.436 | 45.51 | 71.326 | 103.535 | 90.52 | 63.763 | 36.548 | -49.049 | 36.329 | 54.105 | 53.162 | 49.913 | 46.555 |
| Net Income Ratio
| -0.285 | 0.04 | 0.055 | 0.1 | 0.123 | 0.091 | 0.072 | -0.247 | 0.099 | 0.137 | 0.138 | 0.134 | 0.139 |
| EPS
| -0.61 | 0.11 | 0.18 | 0.25 | 0.22 | 0.18 | 0.12 | -0.16 | 0.13 | 0.23 | 0.23 | 0.21 | 0.22 |
| EPS Diluted
| -0.61 | 0.11 | 0.18 | 0.25 | 0.22 | 0.18 | 0.12 | -0.16 | 0.13 | 0.23 | 0.23 | 0.21 | 0.22 |
| EBITDA
| -12.878 | 154.676 | 174.822 | 208.565 | 151.424 | 111.551 | 65.223 | -28.394 | 56.186 | 76.574 | 72.026 | 73.046 | 75.709 |
| EBITDA Ratio
| -0.015 | 0.135 | 0.135 | 0.202 | 0.206 | 0.16 | 0.128 | -0.143 | 0.154 | 0.193 | 0.186 | 0.196 | 0.226 |